Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 3
2007 1
2008 1
2009 1
2010 1
2011 2
2012 2
2013 1
2014 3
2015 1
2016 2
2018 1
2019 3
2020 1
2021 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Type I Interferons in COVID-19 Pathogenesis.
Palermo E, Di Carlo D, Sgarbanti M, Hiscott J. Palermo E, et al. Among authors: sgarbanti m. Biology (Basel). 2021 Aug 26;10(9):829. doi: 10.3390/biology10090829. Biology (Basel). 2021. PMID: 34571706 Free PMC article. Review.
Fighting HIV-1 Persistence: At the Crossroads of "Shoc-K and B-Lock".
Acchioni C, Palermo E, Sandini S, Acchioni M, Hiscott J, Sgarbanti M. Acchioni C, et al. Among authors: sgarbanti m. Pathogens. 2021 Nov 20;10(11):1517. doi: 10.3390/pathogens10111517. Pathogens. 2021. PMID: 34832672 Free PMC article. Review.
Type I IFN--a blunt spear in fighting HIV-1 infection.
Acchioni C, Marsili G, Perrotti E, Remoli AL, Sgarbanti M, Battistini A. Acchioni C, et al. Among authors: sgarbanti m. Cytokine Growth Factor Rev. 2015 Apr;26(2):143-58. doi: 10.1016/j.cytogfr.2014.10.004. Epub 2014 Oct 30. Cytokine Growth Factor Rev. 2015. PMID: 25466629 Review.
A cellular screening platform, stably expressing DENV2 NS5, defines a novel anti-DENV mechanism of action of Apigenin based on STAT2 activation.
Acchioni C, Acchioni M, Mancini F, Amendola A, Marsili G, Tirelli V, Gwee CP, Chan KW, Sandini S, Bisbocci M, Mysara M, ElHefnawi M, Sanchez M, Venturi G, Barreca ML, Manfroni G, Bresciani A, Vasudevan SG, Sgarbanti M. Acchioni C, et al. Among authors: sgarbanti m. Virology. 2023 Jun;583:1-13. doi: 10.1016/j.virol.2023.03.016. Epub 2023 Apr 5. Virology. 2023. PMID: 37060797 Free article.
The development of immune-modulating compounds to disrupt HIV latency.
Remoli AL, Marsili G, Battistini A, Sgarbanti M. Remoli AL, et al. Among authors: sgarbanti m. Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):159-72. doi: 10.1016/j.cytogfr.2012.05.003. Epub 2012 Jul 4. Cytokine Growth Factor Rev. 2012. PMID: 22766356 Review.
Therapeutics for HIV-1 reactivation from latency.
Sgarbanti M, Battistini A. Sgarbanti M, et al. Curr Opin Virol. 2013 Aug;3(4):394-401. doi: 10.1016/j.coviro.2013.06.001. Epub 2013 Jun 28. Curr Opin Virol. 2013. PMID: 23810462 Review.
On the role of interferon regulatory factors in HIV-1 replication.
Marsili G, Borsetti A, Sgarbanti M, Remoli AL, Ridolfi B, Stellacci E, Ensoli B, Battistini A. Marsili G, et al. Among authors: sgarbanti m. Ann N Y Acad Sci. 2003 Dec;1010:29-42. doi: 10.1196/annals.1299.005. Ann N Y Acad Sci. 2003. PMID: 15033691 Review.
Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
Acchioni C, Remoli AL, Marsili G, Acchioni M, Nardolillo I, Orsatti R, Farcomeni S, Palermo E, Perrotti E, Barreca ML, Sabatini S, Sandini S, Parolin C, Lin R, Borsetti A, Hiscott J, Sgarbanti M. Acchioni C, et al. Among authors: sgarbanti m. J Virol. 2019 Aug 28;93(18):e00495-19. doi: 10.1128/JVI.00495-19. Print 2019 Sep 15. J Virol. 2019. PMID: 31243131 Free PMC article.
33 results